CTRI/2022/08/044544
Not yet recruiting
未知
ONCOLOGISTS� VIEWS ON WHAT FACILITATES OR HINDERSREFERRAL OF ADULT CANCER PATIENTS TO YOGA SERVICE IN INDIA
Dr Satyapria Maharana0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Satyapria Maharana
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Oncologists Medical Radiation Surgical and Hematologists if their clinical practice involves referral of adults with either solid or hematological malignancy to yoga therapy services
- •Cancer hospitals or tertiary hospitals with cancer care services having access to yoga therapy services
Exclusion Criteria
- •Participants Non Oncologists and hematologists trainee oncologists and hematologists
- •Setting Private oncology clinics situated independently out of a hospital setting
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Views of cancer specialists on referring a child with advanced cancer to palliative careCTRI/2018/06/014397Kasturba Medical College Manipal22
Not yet recruiting
Not Applicable
Study on the combined scheme of Quxie Capsule in the third-line treatment of metastatic colorectal cancer and the characteristics of the dominant populatiocolorectal cancerITMCTR2200006487XiyuanHospital of CACMS
Not yet recruiting
Not Applicable
A survey to assess oncologists opinion on need for assessment of Adolescent and Young Adult (AYA) cancer survivors in India.CTRI/2021/06/034045Tata Memorial Centre
Completed
Not Applicable
Oncologic Outcome and Quality of Life of patients with node negative vulvar cancer after sentinel node biopsy or systematic inguino-femoral lymphadenectomy - an epidemiological investigatioC51Malignant neoplasm of vulvaDRKS00013298Evangelisches Krankenhaus Kalk97
Not yet recruiting
Not Applicable
Specialist cancer nurse-led telehealth symptom management and care coordination for Australians affected by pancreatic cancer: The PANConnect randomised controlled trialACTRN12624001034527Peter MacCallum Cancer Centre146